Evaluation of Two Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
- Study Title
- Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
- Teva Identifier
- PM034
- ClinicalTrials.gov Identifier
- NCT01167426
- Study Status
- Completed
- Trial Condition(s)
- Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate 20 mg/0.5 mL | Drug: Glatiramer acetate 20 mg/0.5 mL
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2010 - 12/01/2010
- Phase
- Phase 3
